A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.
Clinical trial NCT02521441 · COMPLETED
Trial details
- NCT number
- NCT02521441
- Sponsor
- EVIVE Biotechnology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-03
- Primary completion
- 2015-09-20
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.